
    
      Objective response rate (ORR), disease control rate (DCR) (according to RECIST 1.1 Standard
      Edition)，progression-free survival (PFS), overall survival (OS), quality of life
      (QoL).Evaluation once every 8 weeks, If the efficacy results of the evaluation are complete
      response (CR) or partial response (PR), confirmed imaging efficacy at 4 weeks after the
      initial assessment ， efficacy evaluation time window of ± 7 days.
    
  